GENE ONLINE|News &
Opinion
Blog

2021-08-18| Technology

Scientists Develop Drug Inducible Switch to Regulate Gene Therapy

by Ameya Paleja
Share To
As researchers develop innovative methods to deliver gene therapy, one problem remains - the protein output. Post-delivery, scientists have no control over how much protein the new gene will produce. Too little, the treatment would be ineffective, and too much and the protein can turn toxic for the recipient. To address this, researchers at the Children’s Hospital of Philadelphia (CHOP) have devised a switch that can be turned on with a drug.

GO Prime with only $1.49 now

LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!